Results 51 to 60 of about 1,771,410 (405)

Rheumatic heart disease predisposing to embolic myocardial infarction: a multimodality imaging approach [PDF]

open access: yes, 2016
We report a clinical case of a 45-year-old male with a diagnosis of inferior myocardial infarction and previous history of rheumatic fever during his childhood. Coronary angiography demonstrated normal coronary arteries.
Canali, Emanuele   +4 more
core   +1 more source

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundUnderstanding the relative risk of cardiovascular versus noncardiovascular death is important for designing clinical trials. These risks may differ depending on patient age, sex, and type of acute coronary syndrome (ACS).
Alexander C. Fanaroff   +9 more
doaj   +1 more source

A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI) [PDF]

open access: yes, 2014
Objectives: The aim of this study was to assess whether deferred stenting might reduce no-reflow and salvage myocardium in primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Background: No-reflow
Ahmed, Nadeem   +23 more
core   +3 more sources

Understanding myocardial infarction [PDF]

open access: yesF1000Research, 2018
Over the last 40 years, our understanding of the pathogenesis of myocardial infarction has evolved and allowed new treatment strategies that have greatly improved survival. Over the years, there has been a radical shift in therapy from passive healing of the infarction through weeks of bed rest to early discharge usually within 2 to 3 days as a result ...
Moussa Saleh, John A Ambrose
openaire   +3 more sources

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

open access: yesNew England Journal of Medicine, 1996
BACKGROUND In patients with high cholesterol levels, lowering the cholesterol level reduces the risk of coronary events, but the effect of lowering cholesterol levels in the majority of patients with coronary disease, who have average levels, is less ...
F. Sacks   +11 more
semanticscholar   +1 more source

Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction

open access: yesCirculation, 2020
Supplemental Digital Content is available in the text. Background: The future risk of myocardial infarction is commonly assessed using cardiovascular risk scores, coronary artery calcium score, or coronary artery stenosis severity.
M. Williams   +25 more
semanticscholar   +1 more source

Deep Learning for Cardiologist-level Myocardial Infarction Detection in Electrocardiograms [PDF]

open access: yes, 2019
Myocardial infarction is the leading cause of death worldwide. In this paper, we design domain-inspired neural network models to detect myocardial infarction. First, we study the contribution of various leads. This systematic analysis, first of its kind in the literature, indicates that out of 15 ECG leads, data from the v6, vz, and ii leads are ...
arxiv   +1 more source

Allergic myocardial infarction

open access: yesNorth American Journal of Medical Sciences, 2013
Dear Editor, Anaphylactic shock following wasp sting is an emergency, often treated with intravenous antihistaminics, steroids and epinephrine. The administration of epinephrine in these situations remains controversial, as it worsens the coronary vasospasm and may precipitate a myocardial infarction.
Susmitha Chandragiri   +2 more
openaire   +3 more sources

Third universal definition of myocardial infarction

open access: yesNature Reviews Cardiology, 2013
Authors/Task Force Members Chairpersons: Kristian Thygesen (Denmark)*, Joseph S. Alpert, (USA)*, Harvey D. White, (New Zealand)*, Biomarker Subcommittee: Allan S. Jaffe (USA), Hugo A. Katus (Germany), Fred S. Apple (USA), Bertil Lindahl (Sweden), David A.
K. Thygesen   +53 more
semanticscholar   +1 more source

Determination of Nitric Oxide and Its Metabolites in Biological Tissues Using Ozone-Based Chemiluminescence Detection: A State-of-the-Art Review

open access: yesAntioxidants
Ozone-based chemiluminescence detection (CLD) has been widely applied for determining nitric oxide (•NO) and its derived species in many different fields, such as environmental monitoring and biomedical research.
Junjie Li   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy